Plandai Biotechnology's Cannabis Extracts Could Further Shape Marijuana Debate
April 11 2014 - 9:00AM
Marketwired
Plandai Biotechnology's Cannabis Extracts Could Further Shape
Marijuana Debate
NEW YORK, NY--(Marketwired - Apr 11, 2014) - Plandaí
Biotechnology (OTCQB: PLPL) has a deal in place to brand and market
its future cannabis extracts under the Diego Pellicer Gold label,
and it could be those extracts and the company's work with
cannabinoids that help shape public opinion in favor of using the
drug medicinally. A Pew Research Center survey released last
week found that 75 percent of Americans say they feel the legal
sale and use of marijuana is inevitable whether they support it or
not. While support for marijuana grows, Plandaí and its
extracts could go a long way toward changing the minds of the
drug's opponents.
In the survey, 54 percent of respondents favored legalizing the
use of marijuana which is a dramatic change from just 4 years ago
when in the same survey, only 41 percent thought pot should be
legal. Make no mistake about it attitudes are shifting in
favor of marijuana in this country, and recent interest is likely
due to CNN Chief Medical Correspondent Sanjay Gupta's "Weed"
documentaries that are educating more Americans on the realities of
cannabis. "Weed" documentaries can be seen commercial free at
www.stockmarketmediagroup.com/media.
Dr.Gupta himself was once a staunch opponent of legalizing
marijuana, but he has since become a strong advocate for the use of
cannabis. In those documentaries, Dr. Gupta has highlighted
just how powerful the use of cannabinoids can be as a treatment for
such things as seizures, pain management, cancer and many
others.
Plandaí produces highly bioavailable plant extracts for
industries including health, wellness, nutraceutical, and
pharmaceutical, and will explore the use of both THC and
cannabinoids to develop extracts and to pursue various
pharmaceutical and nutraceutical applications. Dr. Gupta and a
majority of Americans in general agree with Plandaí's CEO Roger
Duffield who said, "The medicinal opportunities associated with
phyto-cannabinoids are simply too great to ignore."
About Stock Market Media Group SMMG is a Research and Content
Development IR firm that offers a platform for corporate stories to
unfold in the media with Reports, Interviews and Articles. SMMG is
compensated for Plandaí articles, reports and interviews by a third
party who reserves the right to buy, sell or remain neutral
on securities at any time before, during, or after the
publication of this article. To date, SMMG has received total
compensation of $40,640, for content related to Plandaí. For
more information: www.stockmarketmediagroup.com/.
Contact: Stock Market Media Group Email Contact
Plandai Biotechnology (PK) (USOTC:PLPL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Plandai Biotechnology (PK) (USOTC:PLPL)
Historical Stock Chart
From Jul 2023 to Jul 2024